Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04VSM
|
||||
| Former ID |
DCL000297
|
||||
| Drug Name |
CS-8958
|
||||
| Synonyms |
Inavir; Laninamivir octanoate; R-118958
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Influenza virus [ICD10:J11.1] | Phase 3 | [1] | ||
| Company |
Biota
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H36N4O8
|
||||
| Canonical SMILES |
CCCCCCCC(=O)OCC(C(C1C(C(C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)O<br />C)O
|
||||
| InChI |
1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1
|
||||
| InChIKey |
UKTIJASCFRNWCB-RMIBSVFLSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [2] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00803595) A Multinational Phase III Study of CS-8958 (MARVEL). U.S. National Institutes of Health. | ||||
| REF 2 | Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.